Abstract

A decrease of IL-6 and procalcitonin (PCT) correlates with survival during sepsis [1]. Coupled plasma filtration and adsorption (CPFA) supports the renal function and removes proinflammatory mediators, but few clinical studies compare the effects of CPFA and CVVHDF, the standard of care in septic patients with renal failure [2]. The aim of this study is to evaluate whether CPFA and CVVHD have a different effect on IL-6 and PCT in septic patients.

Highlights

  • Patients with post-intubation hypotension (PIH) had significantly higher in-hospital mortality

  • In this study we aimed to investigate the relationship between thyroid hormone abnormalities and major cardiovascular events and sudden cardiac death at 3 and 6 months after discharge in patients who were admitted to the Emergency Department with acute coronary syndrome

  • Cuthbertson HG, et al.: The PRaCTICaL study of nurse led, intensive care follow-up programmes for improving long term outcomes from critical illness: a pragmatic randomised controlled trial

Read more

Summary

Introduction

The aim of this study was to assess and compare the ability of the automatically and continuously measured pulse pressure variation (PPV) obtained by an IntelliVue MP monitor and stroke volume variation (SVV) measured by FloTracTM/VigileoTM to predict fluid responsiveness in septic shock patients. Neutrophil gelatinase-associated lipocalin (NGAL) is a novel renal biomarker showing promising results in prediction of AKI in patients across different clinical settings Another potential marker is the resistive index (RI) of renal interlobar artery (calculated as (peak systolic velocity – end diastolic velocity) / peak systolic velocity), which has been shown to be useful in identifying those who will develop AKI in patients with septic shock. Binks R: Prevalence, clinical management and risks associated with acute faecal incontinence in the critical care setting: the FIRST questionnaire survey. Critical Care 2011, 15(Suppl 1):P480

Objectives
Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.